Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 4

Tobacco smoking cessation management: integrating varenicline in current practice

Authors Laurence M Galanti

Published 8 August 2008 Volume 2008:4(4) Pages 837—845

DOI https://dx.doi.org/10.2147/VHRM.S3250

Review by Single-blind

Peer reviewer comments 3

Laurence M Galanti

Clinique Universitaire UCL, Mont-Godinne, Yvoir, Belgium

Abstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the health consequences of tobacco use. The most effective approach assisting smokers in their quit attempts combines both pharmacotherapy and nonpharmacological interventions. This review summarizes the latest international epidemiological data available on tobacco use, considers the associated effects on health, and reviews existing policies against tobacco use. Among the interventions for smoking cessation, the three major pharmacotherapies (which have demonstrated efficacy when combined with behavioral support) are discussed: nicotine replacement therapy (NRT), bupropion, and varenicline. As the newest pharmacotherapy made available in this area, particular consideration is given to varenicline, and a review of our clinical experience is offered.

Keywords: tobacco smoking cessation, nicotinic substitution, nicotine replacement therapy (NRT), bupropion, varenicline

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Ultrastructural localization of intravenously injected carbon nanohorns in tumor

Matsumura S, Yuge R, Sato S, Tomida A, Ichihashi T, Irie H, Iijima S, Shiba K, Yudasaka M

International Journal of Nanomedicine 2014, 9:3499-3508

Published Date: 23 July 2014

The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study

Mark PS Sie, Francesco US Mattace-Raso, André G Uitterlinden, Pascal P Arp, Albert Hofman, et al

Vascular Health and Risk Management 2008, 4:863-869

Published Date: 8 August 2008

Subtemporal approach to basilar tip aneurysm with division of posterior communicating artery: Technical note

Shunsuke Kakino, Kuniaki Ogasawara, Yoshitaka Kubo, Hideaki Nishimoto, Akira Ogawa

Vascular Health and Risk Management 2008, 4:931-935

Published Date: 8 August 2008

Comparative evaluation of 64-slice CT angiography and digital subtraction angiography in assessing the cervicocranial vasculature

Randolf Klingebiel, Max Kentenich, Hans-Christian Bauknecht, Florian Masuhr, Eberhard Siebert, et al

Vascular Health and Risk Management 2008, 4:901-907

Published Date: 8 August 2008

Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers

Camelia R Ban, Stephen M Twigg

Vascular Health and Risk Management 2008, 4:575-596

Published Date: 6 June 2008

Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination

Andreas Pfützner, Birgit Wilhelm, Thomas Forst

Vascular Health and Risk Management 2007, 3:211-220

Published Date: 15 May 2007

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen

Vascular Health and Risk Management 2007, 3:31-37

Published Date: 15 March 2007

A new paradigm of cardiovascular risk factor modification

Muhammad Firdaus, Jeffery M Asbury, Dwight W Reynolds

Vascular Health and Risk Management 2005, 1:101-109

Published Date: 15 July 2005

Nonsteroidal antiinflammatory drugs are associated with increased aortic stiffness

Martin Claridge, Simon Hobbs, Clive Quick, Nick Day, Andrew Bradbury, Teun Wilmink

Vascular Health and Risk Management 2005, 1:149-153

Published Date: 15 July 2005